Table 2 Baseline characteristics of the participants in the TEAMcare for COPD pilot trial
Patients | N = 12 |
|---|---|
Mean age (years) | 64 (11) |
Gender (female) | 9/12 (75 %) |
Education level (High school or less) | 8/12 (67 %) |
Smoking status | |
Current smoker | 2/12 (17 %) |
Former smoker | 8/12 (67 %) |
Moderate-Vigorous exercise (hours/week)a | 2.5 (1.9) |
Fruit serves/day (≥2) | 6/12 (50 %) |
Vegetable serves/day (≥4) | 4/12 (33 %) |
Unintentional weight loss (≥5 kg past 6 months) | 2/12 (17 %) |
Overweight (BMI 25–29.9) | 3/12 (25 %) |
Obese (BMI ≥30) | 7/12 (58 %) |
High waist circumference (≥102 cm men, ≥88 cm women) | 9/12 (75 %) |
High blood pressure (≥130/80 mmHg) | 7/12 (58 %) |
Mean FEV1% (SD) | 58 (16) |
Mean FVC% (SD) | 90 (20) |
Mean FEV1/FVC (SD) | 0.53 (0.13) |
Mean SpOb% | 97 (1.7) |
Inhaled medications | |
LAMA | 7/12 (58 %) |
LABA | 9/12 (92 %) |
ICS | 9/12 (92 %) |
SAMA | 1/12 (8 %) |
Cardiovascular medications | 7/12 (58 %) |
Diabetes medications | 2/12 (17 %) |
Other medications | 7/12 (17 %) |
Impairment (CAT score ≥10) | 8/12 (67 %) |
Breathlessness (mMRC score Grade ≥2) | 4/12 (33 %) |
Clinically relevant depression (PHQ-9 score ≥10) | 1/12 (8 %) |
Clinically relevant anxiety (GAD-7 score ≥10) | 2/12 (17 %) |
Clinically relevant somatic symptoms (PHQ-15 score ≥10) | 3/12 (25 %) |
Blood tests | |
White cell count (x 10^9/L)b | 9.0 (4.7) |
C-Reactive Protein (mg/L)b | 8.5 (4.8) |
25-hydroxyvitamin D (<60 nmol/L) | 7/8 (88 %) |